Trademark: 79334430
Word
U-LOAD
Status
Registered
Status Code
700
Status Date
Tuesday, March 5, 2024
Serial Number
79334430
Registration Number
7318010
Registration Date
Tuesday, March 5, 2024
Mark Type
4000
Filing Date
Friday, November 12, 2021
Published for Opposition
Tuesday, December 19, 2023

Trademark Owner History
Immudex ApS - Original Registrant

Classifications
5 Preparations for pharmaceutical purposes, namely, pharmaceutical preparations for the treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; preparations for medical purposes, namely, diagnostic preparations for medical purposes and medical preparations for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; chemical-pharmaceutical preparations for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; diagnostic preparations for medical purposes; vaccines; diagnostic preparations for analysis for medical purposes, hereunder for each of the abovementioned preparations for medical analysis of vaccines, immunotherapeutics and cellular therapies, in particular cancer vaccines and immunotherapeutics, borrelia vaccines, TB-vaccines, HIV-vaccines and CMV-vaccines, T-cell therapies, and for use in connection with cancer therapy or other therapy, for medical analysis and treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for infectious diseases; diagnostic preparations for analysis for medical purposes, hereunder for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring
1 Chemicals used in industry and science, in the nature of immune related chemicals for immune cell analysis, immune cell monitoring, immune cell detection and immune cell stimulation and immune related chemicals used in science in the nature of MHC monomer and multimer reagents, MR1 monomer and multimer reagents, CD1 monomer and multimer reagents, antibodies, antigen monomer and multimer reagents, reagents, diagnostic agents, control reagents, oligonucleotide conjugated multimer reagents in the nature of DNA/RNA oligo conjugated multimer reagents; diagnostic reagents for diagnostic being research use, other than medical and veterinary use, and scientific use; research diagnostic reagents for scientific use; diagnostic test materials for scientific and diagnostic, other than medical and veterinary, purposes, namely, diagnostic reagents and preparations, except for medical or veterinary use; diagnostic kits for scientific and diagnostic, other than medical and veterinary, purposes comprised of diagnostic reagents and preparations, except for medical or veterinary use and also comprised of immune related chemicals used in science, in the nature of MHC monomer and multimer reagents, MR1 monomer and multimer reagents, CD1 monomer and multimer reagents, antibodies, antigen monomer and multimer reagents, reagents, diagnostic agents, control reagents, oligonucleotide conjugated multimer reagents in the nature of DNA/RNA oligo conjugated multimer reagents; assays for research purposes; biochemical reagents for non-medical purposes, other than medical and veterinary; chemical and diagnostic preparations for analysis for research purposes related to vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TB-vaccines, HIV-vaccines, CMV-vaccines and other vaccines, and for use in scientific research in connection with therapy and immunotherapy, in particular, for use in cancer therapy, cancer immunotherapy, for analysis of T-cell lymphoma, T-cell infiltration of solid tumors and tissue; chemical, and diagnostic preparations for analysis for research purposes related to analysis of infectious diseases, autoimmunity and for use in scientific research in connection with toxicological studies, transplantation, immune monitoring, and vaccines and T-cell monitoring; chemical reagents for other than medicinal and veterinary purposes
YOU LOAD

Trademark Events
Mar 5, 2024
Notice Of Registration Confirmation Emailed
Mar 5, 2024
Registered-Principal Register
Dec 19, 2023
Official Gazette Publication Confirmation E-Mailed
Dec 19, 2023
Published For Opposition
Dec 18, 2023
Notification Processed By Ib
Nov 29, 2023
Notification Of Possible Opposition Sent To Ib
Nov 29, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Nov 29, 2023
Notification Of Notice Of Publication E-Mailed
Nov 8, 2023
Approved For Pub - Principal Register
Nov 8, 2023
Teas/Email Correspondence Entered
Nov 8, 2023
Correspondence Received In Law Office
Nov 8, 2023
Teas Request For Reconsideration Received
Aug 14, 2023
Notification Of Possible Opposition - Processed By Ib
Jul 26, 2023
Notification Of Possible Opposition Sent To Ib
Jul 26, 2023
Notification Of Possible Opposition Created, To Be Sent To Ib
Jul 20, 2023
Notification Of Final Refusal Emailed
Jul 20, 2023
Final Refusal E-Mailed
Jul 20, 2023
Final Refusal Written
Jun 21, 2023
Assigned To Examiner
May 3, 2023
Teas/Email Correspondence Entered
Apr 27, 2023
Correspondence Received In Law Office
Apr 27, 2023
Teas Response To Office Action Received
Apr 2, 2023
New Representative At Ib Received
Nov 14, 2022
Refusal Processed By Ib
Oct 27, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Oct 27, 2022
Refusal Processed By Mpu
Sep 2, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Sep 1, 2022
Non-Final Action Written
Aug 24, 2022
Assigned To Examiner
Mar 1, 2022
Application Filing Receipt Mailed
Feb 25, 2022
New Application Office Supplied Data Entered
Feb 24, 2022
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24